Mereo BioPharma Group PLC (MREO)

3.34 +0.05 (+1.52%) USD  |  NASDAQ  |  Dec 20, 16:00
3.34 0.00 (0.00%) After-Hours: 20:00
More

Mereo BioPharma Group Max Drawdown (5Y): 94.92% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Bicycle Therapeutics PLC 78.82%
TC BioPharm (Holdings) PLC --
Biodexa Pharmaceuticals PLC 100.00%
NuCana PLC 99.46%
DBV Technologies SA 98.19%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -6.145
Beta (5Y) 0.9348
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 123.5%
Historical Sharpe Ratio (5Y) 0.0514
Historical Sortino (5Y) 0.1544
Monthly Value at Risk (VaR) 5% (5Y Lookback) 31.93%